Aquilo Capital Management
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- USA: California
- Massachusetts
- Connecticut
- New Jersey
- Belgium:East Flanders
- Denmark: Copenhagen
Investment stages
- Seed
- Series A
Industries
- Drug Development
- Biotechnology
- Pharmaceuticals
About
Aquilo Capital Management invests in biotech companies using cuttingedge science to tackle urgent medical challenges, aiming for significant returns and transformative impact on healthcare.
Aquilo Capital Management invests in biotech companies using cuttingedge science to tackle urgent medical challenges, aiming for significant returns and transformative impact on healthcare.
Investment Thesis
Aquilo Capital invests in drug development companies that harness the poTheyr of cuttingedge science to address urgent medical needs.
Team
Marc Schneidman Chief Investment Officer
Adam Bristol
PhD Managing Director
Head of Investments
Patrick Rivers Managing Director
Head of Research
Katerina Popova
PhD Vice President
Senior Research Analyst
Christian Sirko Vice President
Senior Research Analyst
Portfolio
Arrowhead Pharmaceuticals
Argenx
Blueprint Medicines
Loxo Oncology
Dicerna Pharmaceuticals
Genmab